Tobias Riët

672 total citations
12 papers, 490 citations indexed

About

Tobias Riët is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Tobias Riët has authored 12 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 4 papers in Genetics. Recurrent topics in Tobias Riët's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Tobias Riët is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Tobias Riët collaborates with scholars based in Germany, Canada and Netherlands. Tobias Riët's co-authors include Markus Chmielewski, Hinrich Abken, Maarten A. Ligtenberg, Álvaro Lladser, Kristina Witt, Rolf Kiessling, Madhura Mukhopadhyay, Dimitrios Mougiakakos, Andreas Hombach and Gunter Rappl and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Tobias Riët

12 papers receiving 483 citations

Peers

Tobias Riët

ONCOL

IMMUN

GENET

Tomohiko Nagai Japan

Kevin Bielamowicz United States

Paris Kosti United Kingdom

Soyeon Kim United States

Marjan Zaman United States

Monica Epstein United States

Claudia Geldres United States

Marissa Cunetta United States

Sanaz Taromi Germany

Ashwini Balakrishnan United States

Tomohiko Nagai Japan

Tobias Riët

550 ×1.5

ONCOL

309 ×1.4

IMMUN

205 ×1.5

166 ×1.4

158 ×1.5

GENET

Citations per year, relative to Tobias Riët Tobias Riët (= 1×) peers Tomohiko Nagai

Countries citing papers authored by Tobias Riët

Since Specialization

Citations

This map shows the geographic impact of Tobias Riët's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Riët with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Riët more than expected).

Fields of papers citing papers by Tobias Riët

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Riët. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Riët. The network helps show where Tobias Riët may publish in the future.

Co-authorship network of co-authors of Tobias Riët

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Riët. A scholar is included among the top collaborators of Tobias Riët based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Riët. Tobias Riët is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Riët, Tobias, Andrea Schienke, Kiara Freitag, et al.. (2023). Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer’s Disease. Cells. 12(16). 2115–2115. 17 indexed citations

Landwehr-Kenzel, Sybille, Niklas Engels, Andrea Schienke, et al.. (2023). Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application. Journal of Autoimmunity. 138. 103057–103057. 35 indexed citations

Roth, Kristian Daniel Ralph, Tobias Riët, Laura Elisa Buitrago‐Molina, et al.. (2023). Generation of Chimeric Antigen Receptors against Tetraspanin 7. Cells. 12(11). 1453–1453. 6 indexed citations

Simon, Daniel, Tobias Riët, Christine S. Falk, et al.. (2022). Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors. Frontiers in Immunology. 13. 1005582–1005582. 17 indexed citations

Riët, Tobias & Markus Chmielewski. (2022). Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges. Frontiers in Immunology. 13. 934343–934343. 31 indexed citations

Zimmermann, Katharina, Daniel Simon, Matthias Hardtke‐Wolenski, et al.. (2022). 334.6: Porcine SLA-Specific Car Treg Enable Xenotransplantation in the Absence of Immunosuppression. Transplantation. 106(9S). S286–S286. 2 indexed citations

Ligtenberg, Maarten A., Dimitrios Mougiakakos, Madhura Mukhopadhyay, et al.. (2015). Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity. The Journal of Immunology. 196(2). 759–766. 177 indexed citations

Cheadle, Eleanor J., Andreas Hombach, Markus Chmielewski, et al.. (2012). Chimeric Antigen Receptors for T-Cell Based Therapy. Methods in molecular biology. 907. 645–666. 36 indexed citations

Rappl, Gunter, Tobias Riët, Annette M. Schmidt, et al.. (2012). The CD3-Zeta Chimeric Antigen Receptor Overcomes TCR Hypo-Responsiveness of Human Terminal Late-Stage T Cells. PLoS ONE. 7(1). e30713–e30713. 11 indexed citations

10.

Riët, Tobias, Astrid Holzinger, Jan Dörrie, et al.. (2012). Nonviral RNA Transfection to Transiently Modify T Cells with Chimeric Antigen Receptors for Adoptive Therapy. Methods in molecular biology. 969. 187–201. 42 indexed citations

11.

Haldenwang, Peter, Klaus Neef, Tobias Riët, et al.. (2012). Evaluation of the use of lower body perfusion at 28 C in aortic arch surgery. European Journal of Cardio-Thoracic Surgery. 41(5). e100–e109. 8 indexed citations

12.

Kofler, David M., Markus Chmielewski, Gunter Rappl, et al.. (2011). CD28 Costimulation Impairs the Efficacy of a Redirected T-cell Antitumor Attack in the Presence of Regulatory T cells Which Can Be Overcome by Preventing Lck Activation. Molecular Therapy. 19(4). 760–767. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact